The tyrosine kinase Lck is a positive regulator of the mitochondrial apoptosis pathway by controlling Bak expression

Oncogene

Volumn 25, Issue 2, 2006, Pages 186-197

  Samraj, A K ^a   Stroh, C ^a   Fischer, U ^a   Schulze Osthoff, K ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Apoptosis; Bak; Bax; Lck; Mitochondria

Indexed keywords

ANTINEOPLASTIC AGENT; CASPASE; CYTOCHROME C; DAUNORUBICIN; DEATH RECEPTOR; DOXORUBICIN; ETOPOSIDE; MITOMYCIN C; OKT 3; PROTEIN BAK; PROTEIN BCL 2; PROTEIN KINASE LCK; PROTEIN P56; PROTEIN TYROSINE KINASE; STAUROSPORINE;

APOPTOSIS; ARTICLE; CANCER; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME REGULATION; ENZYME RELEASE; HUMAN; HUMAN CELL; MITOCHONDRION; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SENSITIVITY ANALYSIS; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TRANSCRIPTION INITIATION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BH3 INTERACTING DOMAIN DEATH AGONIST PROTEIN; CASPASES; CYTOCHROMES C; DRUG RESISTANCE, NEOPLASM; ENZYME ACTIVATION; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; JURKAT CELLS; LYMPHOCYTE SPECIFIC PROTEIN TYROSINE KINASE P56(LCK); MITOCHONDRIA; PROTEIN CONFORMATION; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TRANSCRIPTION, GENETIC;

EID: 30544443793     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209034     Document Type: Article

References (63)

1. Antonsson B, Conti F, Ciavatta A, Montessuit S, Lewis S, Martinou I et al. (1997). Science 18: 370-372.
2. Bantel H, Sinha B, Domschke W, Peters G, Schulze-Osthoff K, Janicke RU. (2001). J Cell Biol 155: 637-648.
3. Battle TE, Frank DA. (2002). Curr Mol Med 2: 381-392.
4. Belka C, Marini P, Lepple-Wienhues A, Budach W, Jekle A, Los M et al. (1999). Oncogene 18: 4983-4992.
5. Cartron PF, Juin P, Oliver L, Martin S, Meflah K, Vallette FM. (2003). Mol Cell Biol 23: 4701-4712.
6. Cheng J, Haas M. (1990). Mol Cell Biol 10: 5502-5509.
7. Cory S, Huang DC, Adams JM. (2003). Oncogene 22: 8590-8607.
8. Daniel PT, Schulze-Osthoff K, Belka C, Guner D. (2003). Essays Biochem 39: 73-88.
9. Datta SR, Brunet A, Greenberg ME. (1999). Genes Dev 13: 2905-2927.
10. Degenhardt K, Chen G, Lindsten T, White E. (2002). Cancer Cell 2: 193-203.
11. Denny MF, Kaufman HC, Chan AC, Straus DB. (1999). J Biol Chem 274: 5146-5152.
12. Desagher S, Osen-Sand A, Nichols A, Eskes R, Montessuit S, Lauper S et al. (1999). J Cell Biol 144: 891-901.
13. Engels IH, Stepczynska A, Stroh C, Lauber K, Berg C, Schwenzer R et al. (2000). Oncogene 19: 4563-4573.
14. Eskes R, Desagher S, Antonsson B, Martinou JC. (2000). Mol Cell Biol 20: 929-935.
15. Essmann F, Bantel H, Totzke G, Engels IH, Sinha B, Schulze-Osthoff K et al. (2003). Cell Death Differ 10: 1260-1272.
16. Ferri KF, Kroemer G. (2001). Nat Cell Biol 3: E255-E263.
17. Finco TS, Kadlecek T, Zhang W, Samelson LE, Weiss A. (1998). Immunity 9: 617-626.
18. Fischer U, Janicke RU, Schulze-Osthoff K. (2003). Cell Death Differ 10: 76-100.
19. Gillissen B, Essmann F, Graupner V, Starck L, Radetzki S, Dorken B et al. (2003). EMBO J 22: 3580-3590.
20. Gonzalez-Garcia A, Borlado LR, Leonardo E, Merida I, Martinez A, Carrera AC. (1997). J Immunol 158: 4104-4112.
21. Green DR, Evan GI. (2002). Cancer Cell 1: 19-30.
22. Griffiths GJ, Dubrez L, Morgan CP, Jones NA, Whitehouse J, Corfe BM et al. (1999). J Cell Biol 144: 903-914.
23. Gruber C, Henkel M, Budach W, Belka C, Jendrossek V. (2004). Biochem Pharmacol 67: 1859-1872.
24. Hanke JH, Gardner JP, Dow RL, Changelian PS, Brissette WH, Weringer EJ et al. (1996). J Biol Chem 271: 695-701.
25. Hernandez-Hansen V, Mackay GA, Lowell CA, Wilson BS, Oliver JM. (2004). J Leukocyte Biol 75: 143-151.
26. Hur YG, Yun Y, Won J. (2004). J Immunol 172: 79-87.
27. Iwamoto KS, Mizuno T, Ito T, Tsuyama N, Kyoizumi S, Seyama T. (1996). Cancer Res 56: 3862-3865.
28. Kane LP, Lin J, Weiss A. (2000). Curr Opin Immunol 12: 242-249.
29. Klee M, Pimentel-Muinos FX. (2005). J Cell Biol 168: 723-734.
30. Knudson CM, Johnson GM, Lin Y, Korsmeyer SJ. (2001). Cancer Res 61: 659-665.
31. Kondo S, Shinomura Y, Miyazaki Y, Kiyohara T, Tsutsui S, Kitamura S et al (2000). Cancer Res 60: 4328-4330.
32. Lindenboim L, Kringel S, Braun T, Borner C, Stein R. (2005). Cell Death Differ 12: 713-723.
33. Lindsten T, Ross AJ, King A, Zong WX, Rathmell JC, Shiels HA et al. (2000). Mol Cell 6: 1389-1399.
34. Manna SK, Aggarwal BB. (2000). J Immunol 164: 5156-5166.
35. Manna SK, Sah NK, Aggarwal BB. (2000). J Biol Chem 275: 13297-13306.
36. Melendez J, Turner C, Avraham H, Steinberg SF, Schaefer E, Sussman MA. (2004). J Biol Chem 279: 53516-53523.
37. Mikhailov V, Mikhailova M, Degenhardt K, Venkatachalam MA, White E, Saikumar P. (2003). J Biol Chem 278: 5367-5376.
38. Panaretakis T, Pokrovskaja K, Shoshan MC, Grander D. (2002). J Biol Chem 277: 44317-44326.
39. Pedraza LG, Stewart RA, Li DM, Xu T. (2004). Oncogene 23: 4754-4762.
40. Puthalakath H, Strasser A. (2002). Cell Death Differ 9: 505-512.
41. Qin S, Minami Y, Kurosaki T, Yamamura H. (1997). J Biol Chem 272: 17994-17999.
42. Schulze-Osthoff K, Ferrari D, Los M, Wesselborg S, Peter ME. (1998). Eur J Biochem 254: 439-459.
43. Schwerk C, Schulze-Osthoff K. (2003). Biochem Pharmacol 66: 1453-1458.
44. Schwerk C, Schulze-Osthoff K. (2005). Mol Cell 19: 1-13.
45. Seddon B, Legname G, Tomlinson P, Zamoyska R. (2000). Science 290: 127-131.
46. Sepp-Lorenzino L, Ma Z, Lebwohl DE, Vinitsky A, Rosen N. (1995). J Biol Chem 270: 16580-16587.
47. Singer AL, Koretzky GA. (2002). Science 296: 1639-1640.
48. Skorski T. (2002). Nat Rev Cancer 2: 351-360.
49. Sohn D, Schulze-Osthoff K, Janicke RU. (2005). J Biol Chem 280: 5267-5273.
50. Stepczynska A, Lauber K, Engels IH, Janssen O, Kabelitz D, Wesselborg S et al. (2001). Oncogene 20: 1193-1202.
51. Straus DB, Weiss A. (1992). Cell 70: 585-593.
52. Tamura T, Ishihara M, Lamphier MS, Tanaka N, Oishi I, Aizawa S et al. (1995). Nature 376: 596-599.
53. Tang D, Lahti JM, Kidd VJ. (2000). J Biol Chem 275: 9303-9307.
54. Uckun FM, Waddick KG, Mahajan S, Jun X, Takata M, Bolen J et al. (1996). Science 273: 1096-1100.
55. von Haefen C, Wieder T, Essmann F, Schulze-Osthoff K, Dörken B, Daniel PT. (2003). Oncogene 22: 2236-2247.
56. Wang GQ, Gastman BR, Wieckowski E, Goldstein LA, Gambotto A, Kim A et al. (2001). J Biol Chem 276: 34307-34317.
57. Webb BL, Jimenez E, Martin GS. (2000). Mol Cell Biol 20: 9271-9280.
58. Wei MC, Lindsten T, Mootha VK, Weiler S, Gross A, Ashiya M et al. (2000). Genes Dev 14: 2060-2071.
59. Wei MC, Zong WX, Cheng EH, Lindsten T, Panoutsakopoulou V, Ross AJ et al. (2001). Science 292: 727-730.
60. Williams BL, Schreiber KL, Zhang W, Wange RL, Samelson LE, Leibson PJ et al. (1998). Mol Cell Biol 18: 1388-1399.
61. Willis SN, Chen L, Dewson G, Wei A, Naik E, Fletcher JI et al. (2005). Genes Dev 19: 1294-1305.
62. Wolter KG, Hsu YT, Smith CL, Nechushtan A, Xi XG, Youle RJ. (1997). J Cell Biol 139: 1281-1292.
63. Zamoyska R, Basson A, Filby A, Legname G, Lovatt M, Seddon B. (2003). Immunol Rev 191: 107-118.